TY - JOUR
T1 - Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes
T2 - A national representative population study
AU - Wang, Tiange
AU - Xu, Yu
AU - Xu, Min
AU - Wang, Weiqing
AU - Bi, Yufang
AU - Lu, Jieli
AU - Dai, Meng
AU - Zhang, Di
AU - Ding, Lin
AU - Xu, Baihui
AU - Sun, Jichao
AU - Zhao, Wenhua
AU - Jiang, Yong
AU - Wang, Limin
AU - Li, Yichong
AU - Zhang, Mei
AU - Lai, Shenghan
AU - Wang, Linhong
AU - Ning, Guang
N1 - Funding Information:
This work was supported by the grants 2013BAI09B13 from the National Clinical Research Center for Metabolic Diseases, 2012ZX09303006-001 from the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology, 2012AA02A509 from the National High Technology Research and Development Program of China (863 Program) and 81321001, 81390350, 81222008, 81130016 from the National Natural Science Foundation of China. Dr. Yu Xu was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43TW009107.
Publisher Copyright:
© 2015 applies to the data made available in this article, unless otherwise stated.
PY - 2015/2/26
Y1 - 2015/2/26
N2 - Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.
AB - Background: The diagnosis of diabetes has important clinic implications for the prevention and management of cardiometabolic disorders. We aimed to investigate the awareness, treatment and control of hypertension and dyslipidemia in previously-diagnosed and newly-diagnosed diabetes in Chinese adult population. Methods: We conducted a cross-sectional survey in a nationally representative sample of 98658 Chinese adults aged 18years or older in 2010, using a complex, multistage, probability sampling design. Glycemic status were defined according to the 2010 American Diabetes Association criteria. Hypertension was diagnosed by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Dyslipidemia was diagnosed by the 2004 National Cholesterol Education Program Adult Treatment Panel III. Results: The weighted prevalence of hypertension and dyslipidemia gradually increased in adults with normal glucose regulation, prediabetes, newly-diagnosed diabetes and previously-diagnosed diabetes. Compared to newly-diagnosed diabetes patients, previously-diagnosed diabetes patients were more likely to be aware of hypertension (weighted percentage [95% confidence interval]: 55.2% [52.9%-57.5%] vs 37.6% [35.9%-39.3%]) and dyslipidemia (33.9% [31.8%-36.1%] vs 12.8% [11.7%-13.9%]), to receive blood pressure-lowing (43.7% [41.5%-46.0%] vs 27.5% [26.0%-29.0%]) and lipid-lowering (18.9% [17.2%-20.7%] vs 5.4% [4.6%-6.2%]) therapies, and to have controlled blood pressure (4.7% [3.5%-6.2%] vs 3.5% [2.6%-4.8%]) and lipid (15.9% [12.3%-20.3%] vs 9.5% [6.4%-13.8%]) levels. Conclusions: Detection and control of hypertension and dyslipidemia is far from optimal in Chinese adults, especially in newly-diagnosed diabetes. Improved screening for diabetes is required to promote a better prevention, treatment and control of hypertension and dyslipidemia in China.
KW - China
KW - Control
KW - Diabetes
KW - Dyslipidemia
KW - Hypertension
UR - http://www.scopus.com/inward/record.url?scp=84925186140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925186140&partnerID=8YFLogxK
U2 - 10.1186/s12933-015-0191-6
DO - 10.1186/s12933-015-0191-6
M3 - Article
C2 - 25848699
AN - SCOPUS:84925186140
SN - 1475-2840
VL - 14
JO - Cardiovascular Diabetology
JF - Cardiovascular Diabetology
IS - 1
M1 - 28
ER -